SPOTLIGHT -
FDA approves low-dose pilocarpine hydrochloride 0.4% as a treatment for presbyopia
Qlosi (Orasis Pharmaceuticals) approved to treat presbyopia.
Pipeline: Presbyopia treatment to finish Phase 3 late 2021
Orasis Pharmaceuticals drop in development for treating presbyopia